THE FDA APPROVES HUMAN TRIALS FOR PIG KIDNEY TRANSPLANTS

Summary from the TLDR newsletter

Biotech company eGenesis has received FDA approval to begin human trials of pig-to-human kidney transplants. eGenesis provides pigs with CRISPR-modified genes that reduce the chances of organ rejection in human recipients. Only those 50 or older with end-stage kidney disease will be eligible for trials. They'll also need to be dialysis-dependent and on the kidney transplant waitlist.